🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
Atrial Flutter \[AFL\] is a relatively frequent arrhythmia, considered as b...
Status
Terminated
Location
CHU de Brest
Start Date
2008-07
Trial ID
NCT00736294
The purpose of this study is to determine the effects of pioglitazone, once...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00770497
Treatments Being Tested
This prospective multicenter, double blind study will evaluate the efficacy...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01042392
Treatments Being Tested
The objective was to investigate the relative bioavailability of the fixed ...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT02214966
Treatments Being Tested
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
The study is designed to primarily assess the effect of aliskiren on albumi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302899
The purpose of this study is to determine the efficacy and safety of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00760214
Treatments Being Tested
Study purpose: African Americans with hypertension and markers of metabolic...
Status
Withdrawn
Location
University of Michigan Health System
Start Date
2011-02
Trial ID
NCT01432106
Treatments Being Tested